Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs

Manufacturing has been the key factor limiting rollout of vaccination during the COVID‐19 pandemic, requiring rapid development and large‐scale implementation of novel manufacturing technologies. ChAdOx1 nCoV‐19 (AZD1222, Vaxzevria) is an efficacious vaccine against SARS‐CoV‐2, based upon an adenovi...

Descripción completa

Detalles Bibliográficos
Autores principales: Joe, Carina C. D., Jiang, Jinlin, Linke, Thomas, Li, Yuanyuan, Fedosyuk, Sofiya, Gupta, Gaurav, Berg, Adam, Segireddy, Rameswara R., Mainwaring, David, Joshi, Amar, Cashen, Paul, Rees, Byron, Chopra, Nitin, Nestola, Piergiuseppe, Humphreys, Jonathan, Davies, Sarah, Smith, Nick, Bruce, Scott, Verbart, Dennis, Bormans, Daan, Knevelman, Carol, Woodyer, Mark, Davies, Lee, Cooper, Lisa, Kapanidou, Maria, Bleckwenn, Nicole, Pappas, Daniel, Lambe, Teresa, Smith, Daniel C., Green, Catherine M., Venkat, Raghavan, Ritchie, Adam J., Gilbert, Sarah C., Turner, Richard, Douglas, Alexander D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653296/
https://www.ncbi.nlm.nih.gov/pubmed/34585736
http://dx.doi.org/10.1002/bit.27945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653296/
https://www.ncbi.nlm.nih.gov/pubmed/34585736
http://dx.doi.org/10.1002/bit.27945

Ejemplares similares